key: cord-0837389-u5wclkr2
authors: Ita, Kevin
title: Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
date: 2021-01-11
journal: Arch Med Res
DOI: 10.1016/j.arcmed.2020.12.014
sha: 3da5ec0ed1ebc81a80a9b717d69d06d72a496df1
doc_id: 837389
cord_uid: u5wclkr2

nan

. The storage of COVID-19 vaccines is important from the standpoint of preserving vaccine immunogenicity and efficacy as well as preparing healthcare workers who will be receiving and administering the vaccines (5). The complete, intact mRNA molecule is essential to its potency as a vaccine as a small degradation reaction, anywhere along a mRNA strand, can negatively impact the translation of that strand leading to incomplete expression of the target antigen (6). Following approval by regulatory authorities, mRNA vaccine doses will have to be manufactured, shipped across many cities as well as countries, stored at end-user sites, and subsequently utilized for large-scale vaccination (6). Pfizer's mRNA vaccine has to be stored in a À70 Celsius (À94 degrees F) ultra-cold freezer (5) . The efficacy of the vaccine can decrease if it not stored at a precise temperature (7) . Furthermore, lasting immunity potential and long-term side effects of the vaccine are not known (7) . Time will tell if vaccine-elicited neutralization antibody levels are adequate for preventing or ameliorating COVID-19 disease progression (1) . Lack of knowledge about lasting immunity may complicate the capacity of healthcare providers to plan vaccine timing, dosing, and budgeting (7) . Furthermore, the World Trade Organization was asked to waive some provisions in the international agreements that control intellectual property rights with the aim of accelerating efforts to control the COVID-19 pandemic and ensure that developing countries are not left behind (8) due to financial limitations. Another ear of concern is the possibility of patients and healthcare workers suffering from needle stick injuries because of COVID-19 vaccination campaigns. Sharp injury can occur due to recapping, mishandling, passing of sharps or leaving the sharps on surfaces (9) . Training can assist in alleviating these problems with the newly approved mRNA vaccine injections. A research group has also suggested the use of microneedles for one of the vaccine candidates in development (10) . The use of microneedles can reduce some of the problems encountered with hypodermic needles (11) .

Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private Partnerships

COVID-19): Current Status and Prospects for Drug and Vaccine Development

Critical Aspects of Packaging, Storage, Preparation, and Administration of mRNA and Adenovirus-vectored COVID-19 Vaccines for Optimal Efficacy

Addressing the cold reality of mRNA vaccine stability

The Miracle Vaccine for COVID-19? Public Health in Practice, 2020100061. 0188-4409/$ -see front matter. Copyright Ó 2021 IMSS

India's costeffective COVID-19 vaccine development initiatives

Prevalence and Perception of Needle Stick Injury Among Health Care Professionals at a Tertiary Care Hospital

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development

Effect of microneedle design on pain in human volunteers

None.